These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34088006)

  • 1. Generation and characterization of an iPSC line (SHCMDLi001-A) from a 12-year-old Chinese Han patient with TRAF7 syndrome and of an iPSC line (SHCMDLi002-A) from a control individual.
    Song X; Feng J; Lan X; Tang X; Xu W; Shen J; Yu G; Jia J; Zhang H; Lu Q; Wu S
    Stem Cell Res; 2021 May; 53():102377. PubMed ID: 34088006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration.
    Cristo F; Inácio JM; Rosas G; Carreira IM; Melo JB; de Almeida LP; Mendes P; Martins DS; Maio J; Anjos R; Belo JA
    Stem Cell Res; 2017 Dec; 25():152-156. PubMed ID: 29136563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
    Tokita MJ; Chen CA; Chitayat D; Macnamara E; Rosenfeld JA; Hanchard N; Lewis AM; Brown CW; Marom R; Shao Y; Novacic D; Wolfe L; Wahl C; Tifft CJ; Toro C; Bernstein JA; Hale CL; Silver J; Hudgins L; Ananth A; Hanson-Kahn A; Shuster S; ; Magoulas PL; Patel VN; Zhu W; Chen SM; Jiang Y; Liu P; Eng CM; Batkovskyte D; di Ronza A; Sardiello M; Lee BH; Schaaf CP; Yang Y; Wang X
    Am J Hum Genet; 2018 Jul; 103(1):154-162. PubMed ID: 29961569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell line (ZZUi028-A) from a 52-year-old Chinese Han healthy female individual.
    Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Zhang R; Xu Y
    Stem Cell Res; 2021 May; 53():102381. PubMed ID: 34088010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line from a Chinese Han child with arrhythmia.
    Hou C; Liu W; Xie L; Zheng J; Chen X; Sun X; Zhang Y; Xu M; Li Y; Xiao T
    Stem Cell Res; 2021 Mar; 51():102183. PubMed ID: 33497884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects.
    Alonzo M; Ye S; Beckman B; Texter K; Garg V; Zhao MT
    Stem Cell Res; 2023 Sep; 71():103156. PubMed ID: 37393719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line from a Chinese Han infant with floating-harbor syndrome accompanied with dilated cardiomyopathy.
    Hou C; Xie L; Qiu Q; Lin H; Liu W; Sun X; Zhang Y; Xu M; Li Y; Xiao T
    Stem Cell Res; 2021 Mar; 51():102182. PubMed ID: 33517121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
    Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
    Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patient.
    Yuan A; Tao R; Yu S; Jing N; Sun J
    Stem Cell Res; 2021 Apr; 52():102227. PubMed ID: 33607468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
    Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
    J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell line (SIAISi010-A) from a 31-year-old healthy donor with Chinese Han genetic background.
    Dai Q; Di W; Zhang Y; Gu S; Zhao J; Zhang B; Wang Y
    Stem Cell Res; 2021 May; 53():102314. PubMed ID: 33799282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual.
    Zhang J; Wei L; Wang R; Li X; Liu Z
    Stem Cell Res; 2020 May; 45():101809. PubMed ID: 32361313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line ATCi002-A from a two-year-old chinese boy with Keipert syndrome.
    Lu X; Mai J; Liu L; Chen X; Shen Y
    Stem Cell Res; 2022 Apr; 60():102706. PubMed ID: 35168097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS).
    Alonzo M; Contreras J; Ye S; Lin H; Hernandez-Rosario L; McBride KL; Texter K; Garg V; Zhao MT
    Stem Cell Res; 2022 Oct; 64():102892. PubMed ID: 35987121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell (iPSC) line (HEBHMUi002-A) from a healthy female individual and neural differentiation.
    Ma J; Zhang J; He J; Zhang Z; Li W; Feng B; Guo R; Amponsah AE; Kong D; Liu A; Song Y; Wei L; Cui H
    Stem Cell Res; 2020 Jan; 42():101669. PubMed ID: 31791011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population.
    Zhang W; Dai Q; Hua Y; Di W; Guo J; Zhao J; Deng Y; Wang Y
    Stem Cell Res; 2021 Mar; 51():102172. PubMed ID: 33472125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of three induced pluripotent stem cell (iPSC) lines from a multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC lines from an unaffected relative of the patient.
    Yoshida S; Okura H; Suga H; Nishitomi T; Sakurai A; Arima H; Matsuyama A
    Stem Cell Res; 2020 Jul; 46():101846. PubMed ID: 32460232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
    Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
    Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.